Roth J - Search Results

1

Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.

Růzicka E, Roth J, Jech R, Busek P. Růzicka E, et al. Among authors: roth j. Mov Disord. 2000 Jul;15(4):734-5. doi: 10.1002/1531-8257(200007)15:4<734::aid-mds1022>3.0.co;2-e. Mov Disord. 2000. PMID: 10928588 No abstract available.

2

[Botulinum toxin in the treatment of blepharospasm. Initial experience].

Růzicka E, Roth J, Diblík P. Růzicka E, et al. Among authors: roth j. Cas Lek Cesk. 1992 Apr 10;131(7):213-6. Cas Lek Cesk. 1992. PMID: 1638609 Czech.

3

[The apomorphine test in the differential diagnosis of Parkinsonism. Initial experience].

Roth J, Růzicka E, Mecír P. Roth J, et al. Cas Lek Cesk. 1994 Nov 7;133(21):665-7. Cas Lek Cesk. 1994. PMID: 7805088 Czech.

4

Apomorphine induced cognitive changes in Parkinson's disease.

Růzicka E, Roth J, Spacková N, Mecír P, Jech R. Růzicka E, et al. Among authors: roth j. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):998-1001. doi: 10.1136/jnnp.57.8.998. J Neurol Neurosurg Psychiatry. 1994. PMID: 8057129 Free PMC article. Clinical Trial.

5

Apomorphine does not influence olfactory thresholds in Parkinson's disease.

Roth J, Radil T, Růzicka E, Jech R, Tichý J. Roth J, et al. Funct Neurol. 1998 Apr-Jun;13(2):99-103. Funct Neurol. 1998. PMID: 9626594

6

Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.

Roth J, Zidovská J, Růzicková S, Havrdová E, Preiss M, Uhrová T, Línek V, Doubek P, Volfová M, Jech R, Bauer J, Růzicka E. Roth J, et al. Sb Lek. 1999;100(1):39-44. Sb Lek. 1999. PMID: 10860124

7

Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease.

Růzicka E, Streitová H, Jech R, Kanovský P, Roth J, Rektorová I, Mecír P, Hortová H, Bares M, Hejduková B, Rektor I. Růzicka E, et al. Among authors: roth j. J Neural Transm (Vienna). 2000;107(11):1297-306. doi: 10.1007/s007020070019. J Neural Transm (Vienna). 2000. PMID: 11145005 Clinical Trial.

8

Atrophy of caudate nucleus in Huntington's disease measured by computed tomography.

Roth J, Havrdová E, Růzicka E. Roth J, et al. J Neurol. 2000 Nov;247(11):880-1. doi: 10.1007/s004150070078. J Neurol. 2000. PMID: 11151423 No abstract available.

9

Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson's disease.

Jech R, Urgosík D, Tintera J, Nebuzelský A, Krásenský J, Liscák R, Roth J, Růzicka E. Jech R, et al. Among authors: roth j. Mov Disord. 2001 Nov;16(6):1126-32. doi: 10.1002/mds.1217. Mov Disord. 2001. PMID: 11748747

10

Colour discrimination impairment is not a reliable early marker of Parkinson's disease.

Veselá O, Růzicka E, Jech R, Roth J, Stepánková K, Mecír P, Solano Z, Preclíková E. Veselá O, et al. Among authors: roth j. J Neurol. 2001 Nov;248(11):975-8. doi: 10.1007/s004150170051. J Neurol. 2001. PMID: 11757962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,903 results

Search Page

Filters